ContraVir Pharmaceuticals Announces TXL Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population Pharmaceutical Investing
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update Biotech Investing
PRA Health Sciences Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance Pharmaceutical Investing
Isodiol International Inc. Provides Update on Be Tru Wellness, Announces New Distribution Agreement With Threshold Enterprises Cannabis Investing News
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences Pharmaceutical Investing
TG Therapeutics Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib Pharmaceutical Investing
Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations Pharmaceutical Investing
Shire, Microsoft and EURODIS Form Alliance to Shorten Diagnosis Times for Children with Rare Diseases Biotech Investing
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Pharmaceutical Investing
